Clinical evidence for neuroprotection in glaucoma.
M Francesca
MF
Cordeiro
Leonard A
LA
Levin
D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D057066:Low Tension Glaucoma / Q000188:drug therapy*; D008297:Male; D011810:Quinoxalines / Q000627:therapeutic use*; D013999:Timolol / Q000627:therapeutic use*; D014786:Vision Disorders / Q000503:physiopathology*; D014794:Visual Fields / Q000502:physiology*
D058647:Adrenergic alpha-2 Receptor Agonists; D000319:Adrenergic beta-Antagonists; D011810:Quinoxalines; D013999:Timolol